Covid-19 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

Clover’s adjuvant choice for Covid-19 an edge, but comparison with IMV’s, Novavax’s vaccines limited

The shape of the spike protein in SARS-Cov-2 is essential to determining how to target the virus. Credit: Shutterstock